advanced cancer Archives - Amazing Health Advances

Researchers Admit: Chemo Worsens Quality of Life with No Benefit of Overall Survival in Advanced Stage Cancer

The AHA! Team — Fri, 22 Aug 2025 05:22:16 +0000

Dena Schmidt via NaturalHealth365 – Chemo, as a treatment for cancer, has always been controversial with many patients and healthcare providers doubting its efficacy and safety as a cancer treatment. Bottom line: chemotherapy does trigger more harmful effects than beneficial ones, in many cases. Now, researchers admit that chemotherapy can actually accelerate deterioration in cases of late-stage cancer who still have the mobility and energy for daily activities. Another study published in JAMA Oncology also showed that cancer patients with limited or moderate functioning ability feel worse when undergoing chemotherapy. Is chemo worth the effort? The risks and side effects exposed In the words of the study author and lead researcher, Dr. Holly Prigerson, cancer patients who feel good have “the most to lose and the least to gain” through undergoing chemotherapy. Prigerson is a palliative care researcher at New York Presbyterian Hospital in New York and Weill Cornell Medical College. The side effects of chemotherapy are numerous and include loss of appetite, vomiting, diarrhea, anemia, constipation, bladder issues, bleeding, bruising, edema, hair loss, fatigue, infections, neutropenia, lymphedema, memory loss, difficulty concentrating, throat and mouth issues, nerve issues, pain, sexual and fertility issues, insomnia, and more. Other medical professionals have expressed similar concerns regarding chemotherapy administered near a patient’s death. Doctors have long debated whether the strong, toxic chemicals used in chemotherapy bring enough positive effects to justify the debilitating side effects of chemotherapy. Some have referred to this practice of administering chemo to clients with late-stage cancers as harmful at worst and wasteful at best. Cancer patient warning: Chemotherapy hazards outweigh gains and benefits The above study monitored the chemotherapy effects that 312 cancer patients experienced in their final week of life at six oncology clinics in the United States. Within this group, chemotherapy tended to be administered most often to those who were younger, more educated, receiving treatment at a university medical facility, had pancreatic or breast tumors, and presented additional issues besides cancer. They also were able to engage in their normal daily activities. To assess chemotherapy’s impact, caregivers were interviewed shortly after these patients died. Among those who had high functionality in their last week of life, chemotherapy was shown to reduce their quality of life dramatically, even beyond the impact of being in intensive care or on a ventilator. A lower quality of life was reported versus similar patients who didn’t receive chemo. Sound the alarm: Quality of life should be considered in end-stage cancer cases At the very least, clinical guidelines should be reviewed and revised to adjust for this potential harm from chemotherapy near the end of life. After all, quality of life matters in all cancer cases, and areas like pain control, addressing insomnia, and boosting mood, as well as the potential side effects of chemotherapy, should be given greater consideration. Clearly, chemotherapy isn’t helping patients feel better or live longer in many cases. While the objective is often to fight cancer and tumors with every option, terrible side effects and erosion of quality of life are a heavy price to pay. We would hope that medical professionals take a more cautious approach to prescribing chemotherapy, especially in late-stage cases. Editor’s note: Discover the best ways to avoid cancer cell growth naturally, own the Stop Cancer Docu-Class created by NaturalHealth365 Programs. Sources for this article include: NIH.gov Jamanetwork.com Cancer.gov Reuters.com To read the original article click here.

The post Researchers Admit: Chemo Worsens Quality of Life with No Benefit of Overall Survival in Advanced Stage Cancer appeared first on Amazing Health Advances.

Chemotherapy May Fuel Cancer Regrowth: New Research Reveals Disturbing Findings

The AHA! Team — Fri, 18 Jul 2025 05:27:38 +0000

Lori Alton via NaturalHealth365 – According to current statistics, about one million people a year (in the U.S. alone) undergo chemotherapy in an attempt to beat cancer. Yet this toxic treatment has a poor success rate in treating most kinds of cancer, and its benefits can be short-lived. Making the picture even grimmer is the fact that cancer recurrence after chemotherapy is frequently deadly. Now, from the front lines of cancer research comes the disturbing news that one particular type of chemotherapy can actually lead to cancer regrowth and recurrence. One approach to treating cancer creates a breeding ground for cancer stem cells Chemotherapy-induced senescence, often touted as a new weapon in cancer therapy, involves “putting cancer cells to sleep.” The protocol is intended to place cancer cells in a state of arrested growth, where they are alive but not dividing. While senescence is supposed to prevent further cancerous growth, new research shows that it can serve as a sort of “nursery” and safe harbor for cancer stem cells – the most dangerous and treatment-resistant type of cancer cells. A pair of recent studies reveal the consequences of therapy-induced senescence. In an explosive article published in Frontiers in Oncology, Markus Schosserer, Ph.D., wrote that there is ample evidence that senescent cancer cells can produce inflammatory molecules that promote a rich environment for cancer regrowth. In a breakthrough German study published in Nature, the team presented startling conclusions: senescence not only helps cancer cells avoid death but actually transforms them into cancer stem cells. This is very bad news, as stem cells – which can break from a tumor and metastasize throughout the body – are also the most resistant to treatment. Cancer cells can “outmaneuver” induced senescence In the German study, researchers examined human lymphoma cells treated with drugs to induce senescence and discovered they were developing “stemness.” In other words, the lymphoma cells started to express genes vital for maintaining stem cell function. When the team “released” the cancer cells from senescence, they discovered an alarming outcome. The cells began to multiply again – and more rapidly than those that had not become senescent. Although senescence is supposed to be irreversible, the team found evidence that cancer cells can escape it on their own – without the help of the genetic manipulation they used. Testament to this unfortunate possibility is that the scientists found more previously senescent stem cells in tumor patients after lymphoma recurred than had existed in the same individuals when they received their initial treatment. This demonstrated to the scientists that at least some cells had “figured out” how to outwit senescence. Noted professor of experimental oncology Dr. Jan Paul Medema commented, ‘There is compelling evidence … that … when cancer cells escape from senescence, they have an enhanced ability to drive tumor growth.’ Study leader Dr. Clemens A. Schmitt reported that switching off a specific cell signaling pathway could work to neutralize stemness in the previously senescent cells. However, there is no doubt that the study findings pose a definite setback for a formerly promising protocol. In addition, other studies have emerged showing that chemotherapy can do more harm than good. Chemotherapy for breast cancer can spread cancer cells A common protocol for breast cancer patients is to surgically remove tumors after chemo has been administered. The theory is that the chemo will help shrink the tumor while preventing the spread of cancer throughout the body. However, the treatment may accomplish the opposite effect. The toxic chemo drugs may actually switch on a repair mechanism – creating more blood vessel pathways and permitting tumors to grow back even stronger. In a study at the Albert Einstein College of Medicine, researchers found that chemotherapy triggered the circulation of more cancer cells throughout the lungs and the body. Chemotherapy features toxic side effects The American Cancer Society acknowledges that chemotherapy damages healthy cells – and reports that chemotherapy side effects include vomiting, diarrhea, anemia, hair loss, fertility problems, chronic fatigue, and infections. Neutropenia, the most serious side effect, involves the depletion of white blood cells needed to fight diseases and infections. Weight changes and mood changes – with depression, memory loss, and inability to concentrate – may also occur. Normal cells damaged by chemotherapy Normal cells most likely to be damaged by chemotherapy are cells in hair follicles, blood-forming cells in the bone marrow, cells in the mouth and digestive tract, and cells in the reproductive system. Experts report that in some situations – for example, the early stages of colorectal cancer – chemotherapy has been shown to provide some benefit, granting extra years of life. But on the whole, chemotherapy yields disappointing results and may even exacerbate cancer cell growth – as shown in this pair of startling studies. Editor’s note: Discover the many natural ways to stop cancer cell growth, own the Stop Cancer Docu-Class created by NaturalHealth365 Programs. Sources for this article include: NIH.gov Medicalnewstoday.com Sciencedaily.com Cancer.org To read the original article click here.

The post Chemotherapy May Fuel Cancer Regrowth: New Research Reveals Disturbing Findings appeared first on Amazing Health Advances.

Aspirin May Accelerate Progression of Advanced Cancers in Older Adults

AHA Publisher — Wed, 12 Aug 2020 07:00:54 +0000

Massachusetts General Hospital via EurekAlert – Results from a recent clinical trial indicate that for older adults with advanced cancer, initiating aspirin may increase their risk of disease progression and early death. The study, which was conducted by a binational team led by researchers at Massachusetts General Hospital (MGH), the Berman Center in Minnesota, and Monash University in Australia, is published in the Journal of the National Cancer Institute. Compelling evidence from clinical trials that included predominantly middle-aged adults demonstrates that aspirin may reduce the risk of developing cancer, especially colorectal cancer. Information is lacking for older adults, however. To provide insights, investigators designed and initiated the ASPirin in Reducing Events in the Elderly (ASPREE) trial, the first randomized double-blind placebo-controlled trial of daily low-dose aspirin (100 mg) in otherwise healthy older adults. The study included 19,114 Australian and U.S. community-dwelling participants aged 70+ years (U.S. minorities 65+ years) without cardiovascular disease, dementia, or physical disability at the start of the study. Participants were randomized to aspirin or placebo and followed for a median of 4.7 years. In October 2018, the investigators published a very surprising and concerning report showing an association between aspirin use and an elevated risk of death, primarily due to cancer. The current report now provides a more comprehensive analysis of the cancer-related effects of aspirin in the ASPREE participants. “We conducted this study as a more detailed examination of the effect of aspirin on the development of cancer as well as death from cancer,” explained senior author Andrew T. Chan, MD, MPH, Chief of the Clinical and Translational Epidemiology Unit at MGH, Director of Epidemiology at the MGH Cancer Center, and a Professor of Medicine at Harvard Medical School. Dr. Chan and his colleagues reported that 981 participants who were taking aspirin and 952 who were taking placebo developed cancer. There was no statistically significant difference between the groups for developing cancer overall or for developing specific types of cancer. Aspirin was associated with a 19% higher risk of being diagnosed with cancer that had spread (or metastasized) and a 22% higher risk of being diagnosed with stage 4, or advanced, cancer, however. Also, among participants who were diagnosed with advanced cancer, those taking aspirin had a higher risk of dying during follow-up than those taking placebo. “Deaths were particularly high among those on aspirin who were diagnosed with advanced solid cancers, suggesting a possible adverse effect of aspirin on the growth of cancers once they have already developed in older adults,” said Dr. Chan. He added that the findings suggest the possibility that aspirin might act differently, at the cellular or molecular level, in older people, which requires further study. Notably, the vast majority of the study participants did not previously take aspirin before age 70. “Although these results suggest that we should be cautious about starting aspirin therapy in otherwise healthy older adults, this does not mean that individuals who are already taking aspirin–particularly if they began taking it at a younger age–should stop their aspirin regimen,” Dr. Chan added. To read the original article click here.

The post Aspirin May Accelerate Progression of Advanced Cancers in Older Adults appeared first on Amazing Health Advances.